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Abstraet--A general model of the effects of physiological ging changes and systematic 
selection due to death or to morbid changes in a human population is presented. Pa- 
rameter estimation is conducted on large longitudinal data bases. Assuming the avail- 
ability of such estimates, the model is developed in a form suitable for implementation 
on a microcomputer. Consideration is given to simulating the effects of chronic disease 
on a human population using estimated parameter values and using alternative values 
selected to reflect various assumptions about possible interventions. An example is 
developed using data from the Framingham Study of cardiovascular disease. 
1. INTRODUCTION 
Standard statistical models used in assessing the risks of chronic diseases generally assume 
that risk factors (i.e. covariate values) are fixed during the interval between measurement 
times and that each chronic disease operates independently (i.e. the assumption of in- 
dependent "competing risks" (Chiang[1], Gall[2], Prentice et al.[3]). These assumptions 
are inappropriate for evaluating chronic disease risks at advanced ages, where physio- 
logical factors are changing rapidly with age, where physiological homeostasis appears 
to be weaker in most individuals, and where the probability that an individual has multiple. 
interacting chronic diseases is high (Minaker and Rowel4]). To describe disease risks and 
associations with risk factors at these ages, a more detailed model of the biological and 
physical mechanisms i required. Such a model should describe an underlying stochastic 
process producing changes in health and increasing rates of onsets of chronic diseases. 
Explicit representation f the underlying stochastic process describing health changes can 
more accurately describe the special characteristics of disease risks at advanced ages. 
This paper presents a general model of the stochastic processes governing human mor- 
tality and aging (Woodbury and Manton[5]). This model describes the generation of age- 
related physiological changes and mortality as a result of a two component stochastic 
process. The first component is the evolution over age of the physiological state of in- 
dividuals, described by a linear autoregressive process of some specified order, it is 
assumed that stochasticity is generated by an appropriately dimensioned Wiener process. 
The second component of this process is the dependence of an individual's risk of death 
on his physiological status, described by a quadratic function of his current covariate 
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values--v,,here the current status may be estimated from the estimates of the parameters 
of the linear diffusion process describing the continuous changes of those covariates, 
This procedure offers solutions to three analytic problems that arise in the analysis of 
health changes at advanced ages. First, the effects of dependent competing risks are 
reflected in the model because the dynamics of the physiological variables on which each 
component of the overall risk depends are represented. The quadratic hazard function 
for total mortality decomposes into sums of independent quadratic forms for specific 
diseases: with this decomposition positive dependencies between the disease risks for an 
individual are represented through positive associations of causal risk factors with two 
(or more) disease risks. Conversely, causal risk factors being positively associated with 
one disease risk but negatively associated with other disease risks might represent negative 
dependency. Additionally the set of covariates may include indexes reflecting the pos- 
session of specific chronic diseases by the individual le.g. a variable representing whether 
the person is diabetic). This describes a type of asymmetric dependency ~here the de- 
pendence of one disease on a risk factor was altered in the presence of another (i.e. through 
a significant interaction coefficient). This device also enables partial representation f the 
effect of dependent competing risks in the case where not all the physiological covariate 
measurements necessary to describe the effects of the manifest diseases are available. 
Second, the model describes the change of physiological factors with age. This description 
involves both deterministic (the autoregressive equations) and stochastic {the diffusion 
coefficients) components. In the deterministic component the age-related changes of 
chronic diseases can be represented by allowing certain coefficients to be age dependent. 
This can help account for certain nonlinearities in the change and rate of change of certain 
physiological variables at advanced ages. Third, in the stochastic diffusion component. 
age-related changes in the homeostatic stability of individuals can be represented by al- 
lowing the diffusion coefficients to be dependent upon the age evolution of the physio- 
logical variables. This can help account for the increasing heterogeneity of the physio- 
logical status of the extreme lderly (Gordon and Shurtleftl6]. Minaker and Rowe[all. 
Because the statistical estimation strategy is based upon an explicit consideration of
the underlying stochastic processes, the dynamic balance of the various forces of change 
can be represented appropriately. This allows us to develop equations describing the 
evolution of the physiological status of a population and to simulate change in that ev- 
olution at advanced ages. Such forecasts and projections could use the available pide- 
miological and biomedical data to simulate changes at very advanced ages where the 
available data are inadequate to estimate the parameters of the process, although they 
may be adequate to validate certain general physiological features of the population fore- 
casts by the model. In this way, the model would be a tool to evaluate the implications 
of risk factor interventions in the more complex and potentially less stable physiological 
dynamics at those ages. Naturally, such simulation could help determine also the lifetime 
effects of certain risk factor interventions on health. 
In this paper we first present he elements of our two component process and describe 
the maximum likelihood machinery necessary to apply it. In particular we consider the 
implications of competing risks in the equations for estimation. We then show how the 
coefficient estimates may be used to forecast health changes at later ages. We then il- 
lustrate the model using data from the well-known Framingham (Massachusetts) Study. 
2. THE MODEL 
The model of chronic disease evolution and of human mortality and aging which we 
will investigate was developed by Woodbury and Manton[5] for the case of observed 
physiological measurements, and extended by Yashin et a/.[7] to include the effects of 
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unobserved physiological variables. Ho~vever, in our application we shall restrict our 
attention to the case of observed measurements. 
The evolution of a multivariate population distribution function under a stochastic pro- 
cess that includes effects of mortality selection, diffusion, and drift and regression, can 
be described by a generalization of the Fokker-P lanck equation. This generalization i - 
cludes a term to represent he loss of population due to mortality selection, which is a 
systematic function of the individual coordinates in the state space. Woodbury and Man- 
ton[5] showed that the assumptions of (a) linear changes in the physiological variables. 
(b) Gaussian diffusion, and (c) a quadratic force of selection, were sufficient to maintain 
a Gaussian distribution over time, given that the initial distribution was Gaussian. This 
demonstration led to the development of discrete time approximations both for estimating 
the parameters of the process (Woodbury et a/.[8, 91. *lanton et al.[ 10]) and for modeling 
the evolution of the process in discrete time (Woodbury and Manton[ l l ,  12]). In the 
remainder of this section we will provide the mathematical basis of this model. 
Following Liptser and Shiryayev[13]. let {-(o~, t)] (to, t) ~ O, × .Y} be a continuous- 
parameter eal multivariate stochastic process, denoted XIt), defined on a probability 
space ~ = (D., .~, P), where .~- = [0, v], 7 > 0. is an interval of the nonnegative real line. 
Let x(t) denote a realization of X(t), assumed to correspond to the physiological status 
of a given individual at time t, and let x6 = {x(s) I s ~ [0, t]} be the sample trajectory of 
x(t) for that individual over the interval [0, t]. Furthermore, let T be a random variable 
denoting the time of death, or more generally, the time of occurrence of any event that 
alters or terminates the process Xft). It is assumed that the conditional survival function 
of T is 
I/: } P(T> tIx~)) = exp - >(s .x (s ) )ds  ,
where the time varying hazard rate ~,(t, x(t)) is a known quadratic function of x(t), 
(2.1) 
p,(t, x(t)) = ~o(t) + bT(t)x(t) + ½xr(t)B(t)x(t), (2.2) 
where the time varying functions ~o(t), b(t), and 
tality selection is modeled by ~,(t. x(t)). 
Woodbury and Manton[5] in effect assume that 
of an individual can be described by a stochastic 
B(t) do not depend on x(r). Thus, mot-- 
the evolution of the physiological status 
differential equation 
dx(t) = u(t, x(t)) dt + D(t, x(t)) dW(t), 0 --< t - ,r. (2.3) 
where W(t) is a multidimensional Wiener process independent of the initial value x(0). 
where D(t, x(t)) is a bounded matrix of scale /,actors which govern the diffusion at xIt). 
and where u(t, x(t)) is the deterministic component which governs the drift and regression 
of the process. The specification of this last component,  u(t, x(t)), however, is made more 
precise by assuming a linear autogressive structure of the form 
u(t, x(t)) = Uo(t) - A(t)x(t), (2.4) 
where the time varying functions Uo(t) and A(t) do not depend on x(t). It is also assumed 
that D(t) - D(t, x(t)) does not depend on x(t). Thus. the matrix ~(t) = {~]k(t)} is the 
Gaussian diffusion matrix defined by 
~(t) = D(t)Dr(t).  (2.5) 
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3. THE L IKEL IHOOD FUNCTION FOR THE DISCRETE TIME 
APPROXIMATION 
Basically, for the conditions considered, statistical evaluation involves the estimation 
of the parameters of two linked discrete time processes. The first process describes the 
evolution of the physiological factors as driven by a first order linear deterministic and 
stochastic omponent. The equation system of n physiological variables, say x,, t = O, 
1 . . . . .  -r, may be written as 
xt . t  = u, + R,xt  + e~, (3.1) 
where the coefficients u, and R, represent regression coefficients for the values observed 
at time t + 1 regressed on their prior values at time t. The diffusion matrix £,  = 
g(E,ET) is of order n. Its structure determines the form of estimation procedures (e.g. if 
Z, is diagonal with equal size variances for observations, then OLS might be employed). 
Note that R, can be made an explicit function of age by including appropriate age inter- 
action terms. Also note that A, = I - R, is the discrete time analogue to AIt) in (2.4). 
The second component of estimation is the quadratic hazard function. The discrete 
time form of the cumulative hazard. IS,(x,). for the half-open interval It. t + I] is written 
as  
p.,/x,) = ~, + bJx, + ½xIB,x,. 13.2) 
where p.,, b,, and B, are parameters to be estimated. In writing the hazard function in 
this way, we need to emphasize that knowledge of the exact time of death t + 0, 0 < 0 
-< 1, is not assumed. 
The likelihood function for the evolution of the population with change in the physi- 
ological variables and mortality selection parameterized as in eqns (3.1) and 13.2) may be 
written (Manton and Woodbury[14]) 
" t - I  
z = H fo(x,o). 17 1 17 f , - , (x, ,+, 
i~S  0 t ~ 0 i~Sr  ~ I 
x~, )exp[ -  p.,(x,,)] 1-1 {1 - exp[ -  p.,(x,,)]}], 
i~St  ~ I 
(3.3) 
where S, denotes the set of individuals alive at time t, and S,_~ denotes the set of indi- 
viduals whose time of death (or, more generally, of any other event hat alters or terminates 
the process X,) is t + 0 in the interval ( t, t + l ] :hence,  S, = S ,_~US, - , :andwhere  
f,(xi,) -= f(x,-(t) [ T; > t) is the conditional multivariate normal density function given 
survival to time t; and f , -~(xi , -~ I x,.,) - f(xAt + 1) I xi(t). T~ > t + I) is the multivariate 
normal density function at time t + 1, conditional on the prior set of measurements. 
We see that this function factors into three independent terms. The first term. involving 
all mentions of fo(x~o), is the likelihood of the initial conditions, i.e. it is the distribution 
observed at the start of the study. For the Gaussian process described above we assume 
fo(x~o) is a multivariate normal density function with a vector of means Vo and covariance 
matrix Vo; hence, Xo - N(vo, Vo). The second term, involving all mentions of 
f,~-~(x~,+ ~ ] xi,), is the likelihood of the follow-up data at time t + 1. given the observed 
data at the prior time t. Assuming the first order autoregressive process in (3.1). it follows 
from Woodbury and Manton[5] that X,_ ~ - N(u, + R,x,, £,).  The third term. involving 
all mentions of ~,(x;,), is the likelihood of survival and nonsurvival for discrete intervals 
of observation. Under the assumption that the order of the process is correctly specified 
in the second and third terms of this factorization, it follows that maximum likelihood 
estimation of the parameters of each of the factors may be conducted separately. Esti- 
General model tbr assessing impact of chronic disease 1159 
mation of the Gaussian parameters Vo. Vo, u,, R,. £, .  is standard te.g. Draper and 
Smith[15]). In the following sections we will consider only the mortality component of 
the likelihood in greater detail. 
4. COMPETING RISKS 
The question of competing risks focuses primarily on the mortality component of the 
likelihood. Clearly. for eqn (3.3) as written for total mortality, the issue of competing risks 
does not arise. Suppose. however, that we observe not only the fact of death in the interval 
(t, t + 1] but also the cause. Naturally, we are assuming that it is meanin~'ul to attribute 
each death to only one given cause (WHO[16]). Then with each death attributed to one 
of K causes we assign each decedent o one of K cause-groups denoted S~,_, . j  = I. 2. 
. . . .  K. Let gj(t, x(t)) be the time varying cause specific failure rate at time t. given x(t). 
Assume that this is also of quadratic form 
txj(t, x(t)) = ~xjo(t) + b](t)x(t) + ½xr(t)Bi(t)x(t) (4.1) 
with the discrete time approximation for the interval (t. t + 1] 
~j,(x,) = ~j, + b Ix ,  + ½xrBi,x,, (4.2) 
where ~,, b,. and B, in (3.2) are assumed to derive from summation over j of ~.,. bi,. 
and Bj,. Clearly, these conditions imply 
P( J  = j ]  t < T <- t + 1. x,) = ~j,(x,)/p.,(x,), (4.3) 
which is a conditional form of the proportional hazards assumption (Chiang[l]. David[17]. 
Gail[2]). 
We can isolate the mortality component of the total likelihood as 
T- - I  
3f,w = H H exp[-~x,(xu)] H 
t = t) iES~ ~ I iE ,g r  ~ I 
{I - exp[ -  ~-,(xu)]}. (4.4) 
In view of (4.3) it follows that the assignment of each death to one of K cause-groups 
yields a modified form of (4.4), 
" r - I  K 
~'w'= ,=oH ies,.,H exp[ -  ~x,(x,,)] j=l~I= ~es,,.,H/xJ'(xi') {I u.( )_,_xi, - exp[ -  ~-Axu)]}. (4.51 
For estimation purposes, it is desirable to factorize (4.5) into the product of K independent 
factors, each of the form (4.4). This can be done approximately, using the relationship 
I - exp[ -  ~,(x,)] = ~x,(x,) exp[ -  ~ ~x,(x,)]. (4.6) 
which, for Is,(x,) -< 0.05 has a maximum relative error, era,., -< 0.0001; even for p.,(x,) -< 
0.50. em,~ -< 0.01. Substitution of the rhs of (4.6) for the final term in (4.5), followed by 
decomposition of ~.,(x,) into sums of ~j,(x,), yields 
K T~I  
H H H H 
j=  I t=O i~S i ,  ~ t /~ .S ' ; r  ~ I 
~j,(xi,) exp[ - Oi, g i,(xi,)]. (4.7) 
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where S i t - t  is the complement of'S/t-I in S,; hence. Si ,_ t  = St - -S, -~ = S , -~ + (S , - t  
- S j , -  t). where " +'" denotes the union of two disjoint sets. Clearly. 0, = 1. for i 
S,_ t and 0, = ~. for i E S , _ , .  Thus. substitution of the lhs of(4.6) for the final two terms 
of (4.7). adjusted to reflect the cause specific subscripts j. yields 
A." T--I  
3~,,-= 1-[ I-[ 1-[ exp[-0:, la, , (x,)]  1-I 
j=  I t~O i~S/ t  - I i~-- .9: ,  - I 
{1 - exp[-20,pv,(x, ) ]}.  (4.8) 
which is a product of K terms, each of which is of the form (4.4). Thus the parameters 
of each cause specific hazard function may be estimated separately. 
The likelihood function (4.8) readily adapts to three deviations from the observation 
plan which frequently occur in_practice. First. the actual time of death, t + 0, may be 
observed. In this case. for i E S ,_  ~, one can set 0,., in (4.8) to the observed value, under 
the assumption that the hazard is constant over the interval (t, t + 1] (Breslow[18]). 
Second, cases may be lost to follow-up (censored) for a variety of reasons, some possibly 
correlated with an individual's risk factor measurements, These censoring mechanisms 
may be treated as competing risks, conditionally independent of the causes of death under 
study. In such case, V-,Ix,) would be the combined force of mortality and loss to follow- 
up; however, assuming the censoring mechanisms are indexed j  = K* + 1. K* + 2, 
:g 
. . . .  K. the force of mortality la, (x,) would be obtained from (4.8) as 
:g 
t*, (x,) = txz,(x,) + "" + ~,v-,(x,). (4.9) 
if the actual time of censoring were known, then it could also be included by setting 0i, 
to the appropriate value. Third. the actual time of follow-up for survivors may be variable. 
In this case, we would index the individual measurement times and, for i E S : - , ,  set 0,: 
= t~:_ t - tit; for i E Sz-~. set 0, = (time of death): - t,, Additional modifications, 
however, would be required to estimate u,, R,, and Z, in the risk factor dynamics. 
5. ESTINIATION OF THE QUADRATIC HAZARD 
We consider estimation of the parameters ~,, b,, and B, in (4.4). Estimation of the 
cause specific parameters in (4.8) is a trivial generalization using xi, *-- 0,';:x,,. Further- 
more, given the factorization of (4.4) over time we can restrict our attention to the single 
*r in terva l ( t . t  + l ] . Le tx ,  = (l: x]) and let C, bethe(n  + l )by(n  + l) upper triangular 
matrix with nonnegative diagonal elements uch that 
In view of (3.2) we have 
~,(x* )  * ,~r~ * = Xt  L , t  I . . . , tX t  • (5.1) 
.,b,. 7 
Because ¢,(x*) is strictly nonnegative, the admissible stimates of the parameters la,,, b,, 
and B, are restricted to the form (5.2) and the estimation can be conducted in terms of 
C, in the alternative parameterization (5.1). 
Finding maximum likelihood estimates of the parameter matrix C, is equivalent o 
finding the solution C, to the likelihood equations 
,0 
0 = - -  In ~.w,(C,), (5.3) 
Oc/k :  
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where the tth term of ~w in (4.4) is regarded as a function of C~. These estimates are 
found using a modified Newton-Raphson search based on the equations (Stallard et 
a/.[19]) 
L, = In ~.wAC,) (5.4a) 
= ~ ln{exp[>,(x;*, Ct)] - 1} - Tr{CrQ~C~r}, (5.4b) 
where 
Qt  Z * *T = x~,x~, (5.5) 
i~St 
rz 
OL, = 2 ~] yu,x,'~j=,t(x,*, Ct) - 2 ~ q~,,,,c,.,,,,. ( j  <- k), (5.6) 
OCJ kt i~.g', ~ I m =J 
where 
y,, = C,x~*, (5.71 
-O=L, 
-4Y .  
OCjktOC Imt i~g't ~ I 
Z 2t ( Xi*t. C t )y i jt.r,kty il,.ri,,,t 
+ 2 8.il[qk .... -- ~ .riktxi,,,j=l,(x~. C,)]. ( j  < k" l -< m). (5.8) 
iE.9~ * i 
where 8i~ is the Kronecker delta having the value 1 when j = l and 0 when j # l, and 
where 
z , , (x* ,Ct )  = 1 - exp[ ->t (x* .Ct ) ] .  
z2t(x*, Ct) = exp[ ->t (x* ,  C,)]/{I - exp[-~t(x ,* ,  C,)]}=. 
(5.9) 
(5.101 
An estimator of the parameter covariance matrix, obtained as a byproduct of the search 
algorithm, is the inverse matrix of second order partial derivatives (Efron and Hink- 
ley[20]). Covariances of >,, br, and Bt can be obtained from the covariances of the pa- 
rameters in C, using the "delta method" (Deming[21]). 
6. EST IMATION AND FORECAST ING OF THE SURVIVAL  FUNCTION 
With estimates of the parameters Vo, V0, u,, R,, Xt, and either p.,, b,. and B,. or sets 
of Djt, bj,. and Bit, j = I, 2 . . . . .  K, the maximum likelihood estimates of Pt ~ P ( T > 
t), t = 0, I . . . . .  ~, are obtained from the recursive quations (Woodbury and Manton[l 1]) 
Po  = | , 
P , - I  = P , [  I + V ,B , [ - J /2  
v , . i  = u, + R~v*.  
V,+l = x'_, + R ,V ,R , ,  
{ ~(v, )  + ~(vT)  exp 2 - 2V- vt + vr . 
(6.1/ 
(6.2) 
(6.3) 
(6.4) 
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where X~, ~ ~,(v, .  V, ). i E S,_ ~, is the conditional distribution of X,,. given survival to 
t + 1" hence. 
Pt* = v, - Vr*(b, + Brv,), 
V*, = V, - V,[(I + B,V,)-~B,]V, 
= (I + V ,B , ) - IV~.  
(6.5) 
(6.6a) 
(6.6b) 
These are precisely the equations required to ensure that X,-,. ~ - N(v,_  ~. V,_ t). given 
that Xi, - N(v,. V,) .  
These equations can be simply solved using matrix computations on any reasonably 
sized microcomputer.  Modification of different elements can reflect different models of 
control of the aging process through intervention in risk factor levels or dynamics. Fur- 
thermore the utility of such an approach can be extended by introducing the following 
two functions to facilitate comparisons of the effects on the survival function of various 
simulated interventions. The first function is the mean residual life function, or residual 
life expectancy, at time t, defined as d, = ~(T  - t [ T > t) or, in terms of P, as 
f 
z< 
d, = P,  ds/P, (6.7) 
which can be estimated assuming a piecewise constant hazard (Hoem[22]) as 
~, = ~, (P, - P ,_ , ) / ( I I ,P , ) ,  (6.8) 
where 
h,. = ln (P)Ps+ ,). (6.9) 
The second function is the present value at time zero of the cumulative direct and indirect 
costs of mortality from time t onward, defined on a per capita basis as a deferred con- 
tinuously varying life insurance (Jordan[23]), 
eAo = - (1 - d)" ks dP, ,  (6.10) 
where d is the effective rate of discount and ks is the total S-cost assigned to a death at 
time s. Assuming a piecewise constant hazard yields the approximation 
,iAo = ~ exp[ -6s lk ,hsP , .{1  - exp[ - (6  + h,)l} 
,=, (6 + h , )  
(6.11) 
where g is the force of interest associated with the interest rate i, i.e. 
g = ln(l + i) = - ln(l - d). (6.12) 
Further details of the analysis of observed and simulated survival functions from an ac- 
tuarial perspective are presented in Tolley et a/.[24, 25]. 
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7. AN APPLICATION TO THE FRAMINGHAM STUDY 
The next two sections present examples of the analysis of total mortality and of mor- 
tality due to cancer and noncancer causes among males in the first 20 years of the Fra- 
mingham Heart Study. Details on the design of the study, as well as an extensive bibli- 
ography, can be found in Gordon and Kannel[26]. For our purposes, the Framingham 
Study can be characterized as a cohort study on 2336 males examined biennially at 10 
times beginning in September, 1948. These examinations included measurements on n = 
9 risk factors that we will model: age (yrs), pulse pressure (mm Hg), diastolic blood 
pressure (ram Hg), relative weight (ratio to median value in sex-height subgroup), serum 
cholesterol (mg/100 ml), blood sugar (mg/100 ml), hemoglobin (dg/100 roll, vital capacity 
(cl), and smoking (cigarettes/day). The age range at exam 1 was 29 to 62 years, and at 
exam 10, 47 to 79 years. During the interval between exams 1 and 10,473 deaths occurred 
of which 105 were due to cancer: 276 deaths were due to cardiovascular diseases with 
the remaining 92 attributed to other causes. Mortality follow-up was deemed to be com- 
plete (lVlcGee[27]} and survival status was recorded at the time of each exam. 
Let the time units be rescaled to reflect 2-year measurement intervals and assume that 
the covariates are multivariate normal: then the joint likelihood of the risk factors and 
the observed survival status just described is the function (3.3). Maximum likelihood 
estimates of the parameters Vo, Vo, u,, R,, £, ,  ~,,. b,, and B, are obtained under the 
assumption of a first order autoregressive stationary stochastic process. Thus, all param- 
eters are modeled as constant over time. Note, however, that with age included as a 
covariate the process parameters are not  assumed constant over age: i.e. both linear and 
quadratic effects of age are represented. The parameter estimates are given in Table l 
(except for £, ,  which is given in a conditional form for use below). Furthermore, the 
quadratic hazard parameters b, and B, are in the form of (5.2) and assume the origin shift 
x, ~ xt - {o, where {o is given in Table 1; these parameters yield the cumulative hazard 
for a 1-year interval. 
In a second analysis two sets of mortality parameters were estimated for cancer and 
noncancer deaths using the cause specific likelihood mortality term in (4.8). These two 
functions can be combined as shown in (4.9) to yield an alternative set of parameter 
estimates for the total force of mortality. These alternative parameter estimates are pre- 
sented in Table 2. 
Comparison of the two sets of estimates hows them to be in good agreement. Fur- 
thermore, the likelihood ratio test of the improvement of the fit of the model in Table 2 
over that in Table I is not significant (X z = 31.88; 27 df, because the rank of each Ct was 
fixed at 3). Additional details on model fitting and substantive interpretations of parameter 
estimates will be reported elsewhere. Here, it will suffice to note that we also conducted 
separate analyses for smokers and nonsmokers. 
8. ESTIMATES,  FORECASTS,  AND S IMULATED INTERVENTIONS 
A primary motivation for the model is the ability to represent the natural history of 
chronic disease processes in a form amenable to simulated intervention. Using the pa- 
rameter values in Table 1, we projected the survival experiences of a cohort aged 30 years. 
The initial mean vector/ 'o in Table 3 was estimated from the data for 29- to 34-year-old 
Framingham males; the initial covariance matrix "¢o was obtained by pivoting on age in 
the covariance matrix in Table 1; and ~, was obtained by solving (6.4) under the condition 
V,+ t = V* = "v'o, which preserves the covariance over time, except for the effects of 
mortality. With age as a risk factor, the cohort projection is implicitly time dependent. 
The cost estimates in Table 3 use k, values from Rice and Hodgson[28] (i = 0.06) and 
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reflect age specific discounted lost lifetime earnings due to mortality. One can see that 
the initial life expectancy at age 30 is 45.3 years and that 41.1% of this cohort projects 
to live to age 80 years or older. The comparable stimates using the parameters in Table 
2 are 45.0 years and 40.7%, respectively. The mean smoking level drops to zero at age 
80. reflecting a combination of declining consumption among smokers and selective mor- 
tality at higher levels of consumption. 
Table 4 illustrates the effect of total elimination of cancer mortal ity-- increased life 
expectancy at age 30 (48.2 years) and increased survival to age 80 (48.6%1. Note that 
these calculations are quite different from the effects computed under the standard in- 
dependent competing risk model (Keyfitz[29]), where the force of mortality due to cancer 
is assumed unconditionally independent of the force of mortality due to noncancer causes. 
In our calculations we make the weaker assumption of conditional ton x,) independence. 
To the extent that x~ measures causal risk factors, the calculations in Table 4 represent 
the effects of dependent competing risks. 
To further explore the role of cigarette consumption, separate analyses were conducted 
for smokers and nonsmokers. The projections for smokers are presented in Table 5. One 
can see that the life expectancy for smokers is only 43.5 years, 1.8 years less than average. 
and 4.3 years less than the value estimated for nonsmokers (47.8 years/. This is true 
despite the finding that the smoking levels among surviving smokers also approach zero 
at the oldest ages. 
9. EFFECTS OF DIFFUSION 
A basic assumption in the specification of a linear autoregressive process of some given 
order is that the stochasticity induced by the diffusion process would balance with the 
deterministic omponent to preserve the variance of the distribution over time. It is of 
interest o determine how a different mix of deterministic versus stochastic ontributions 
to the total variance affects the survival function. For example, a special case of interest 
is the situation where individual risk differences are assumed fixed through t ime--an 
assumption made in several models designed to evaluate unobserved heterogeneity in risk 
by a distributed parameter form of the hazard function. 
To investigate this we will use the parameter estimates/,~, {'o. f~,. I~,. 4-. lk,, I~,. and 
I~, reported in Manton and Woodbury[30] and derived from an analysis of similar survival 
among 2404 males in the Kaunas, Lithuania, Intervention Study conducted in collabo- 
ration with the World Health Organization. This simply illustrates that the forecasting 
equations presented in Section 6 can be applied with any available set of parameters. 
Table 6 contains the life expectancy results under four different assumptions about 
diffusion. 
Assumption 1 sets u, to zero (except for the age coefficient) and R, = I. the identity 
matrix. The result is that the drift and regression are removed from the projection and 
the diffusion is left unchecked except by the force of mortality. The life expectancy at 
age 30 is projected to be 44.8 years, not very different from when u, and R, were unaltered 
(44.6 years). Assumption 2 sets Z, = ½Vo, R, = (½I) °5, and ut = (1 - (½)°-~)vo. except 
for the age coefficients which are untouched. The result is that drift is removed from the 
projection and diffusion exactly balances the effects of regression: only mortality disturbs 
the equilibrium. The life expectancy at age 30 increases 7.0 years to 51.8 years indicating 
that diffusion and regression both have a major effect on mortality. 
Under Assumption 3. Z, = 0, ut = 0 (except for the age coefficient), and R, = I. Thus 
the effects of drift, regression, and diffusion are all removed. The difference between 
Assumptions 2 and 3 (about ½ year) is relatively small. This suggests that the assumption 
of fixed covariate values over an interval of observation can provide a reasonable ap- 
General model for assessing impact of chronic disease 
Table 6. Residual life expectancies in a cohort aged 30 years under tour alternative as- 
sumptions about the mixture of diffusion and regression contributing to the total variance 
of the model of survival with covariates: based on parameters derived from the survival 
experience of males in the Kaunas Study[30]  
I169 
Assumption 
t Age (i) (2) (3) (4) 
0 30 &4.84 51.83 52.34 55.32 
5 35 40.05 47.08 47.60 50.39 
i0 40 35.47 42.42 42.94 45.52 
15 45 31.13 37.87 38.39 40.74 
20 50 27.10 33.46 33.99 36.08 
25 55 23.40 29.24 29.77 31.57 
30 60 20.09 25.24 25.77 27.28 
35 65 17.18 21.50 22.03 23.23 
40 70 14.66 18.06 18.59 19.49 
45 75 12.52 14.96 15.49 16.09 
50 80 10.70 12.21 12.73 13.06 
55 85 9.16 9.82 10.31 10.42 
Assumption: 
( I )  u,  = 0: Rt  = l--Diffusion dominates over regression. 
(2) ~-, = .~Vo; R ,  = ( '1 )< ' ;  ut = (1 - ( ' )~~)v~- -D i f fus ion  and regression in equilibrium, 
(3) ~-, = 0: u,  = 0: R ,  = l - -No  diffusion, no regression, fixed covariate values. 
(4) ~£t = 0; u, = 0: R,  = I :  V,  = 0--Homogeneous population. 
Note. These specifications exclude the age covariate. 
proximation to the opposing forces of diffusion and regression, provided the two are in 
equilibrium and drift is not a factor. Thus the fixed frailty types of model (e.g. Manton 
and Stallard[31], Hougaard[32]) may provide reasonable approximations to the mortality 
trajectories predicted by the full diffusion process. Assumption 4 imposes the additional 
condition that V, = 0. Thus the difference in life expectancy (3.0 years) reflects the effect 
of assuming homogeneity when in fact the population is heterogeneous. 
10. CONCLUSION 
This paper (a) presented a new model for analyzing chronic disease risk and risk factor 
changes, (b) illustrated the analysis of total and cause specific mortality experience in the 
Framingham Study, (c) projected the future survival characteristics of the Framingham 
population based on that experience, and (d) illustrated how the elimination of cancer 
mortality would affect the future survival of the Framingham population, under a depen- 
dent competing risk formulation. We also briefly evaluated the effects of disequilibrium 
between the forces of diffusion and regression. 
One observation of particular methodological interest was the fact that models where 
individual differences in risk were fixed could well approximate the mortality trajectory 
derived from the diffusion process. Our goal in this analysis differed from those of standard 
statistical analyses of longitudinal survival data. Rather than attempting to demonstrate 
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statistically significant associations between a select set of risk factors and disease risks, 
our goal focused on taking a known set of risk factors and exploring the biological mech- 
anisms and processes underlying their operation as risk factors. This required developing 
a simple, yet biomedically realistic model to exploit all of the information on the process 
structure available in the dataset. By analyzing the structure of risk factor and risk pro- 
cesses, one can improve the ability to forecast he future health state of the population, 
and the capacity to project various types of interventions. This can have a wide range of 
practical benefits in that the experience from longitudinal survival studies can be used to 
more directly forecast changes in health effects in a form that is comprehensible by health 
policy planners. Thus, the methodology discussed in this paper was specifically designed 
to present he mathematical modeler with a simple, yet powerful set of matrix procedures 
that can be utilized both in specialized scientific investigations and in translating the results 
of such investigations into projections and forecasts that are meanin~ul  to the 
nonspecialist. 
Implementation of the methodology requires four specific tasks to be performed. First, 
the longitudinal data records must be sectioned into records for each examination con- 
taining (1) the vector of risk factor measurements,  (2) an indicator of whether the person 
survived to the next examination. (3) an indicator of the cause of death for nonsurvivors, 
and (4) a time variable giving the interval between follow-up examinations for survivors, 
and, if known, the interval between the examination and the time of death for nonsurvivors. 
Second, the initial means uo and covariances Vo can be obtained from the data on the 
initial examination. Also each adjacent pair of examinations, assuming a first order pro- 
cess, should be linked to obtain u,. R,, and 51,. In our example, we estimated Vo and 51o 
from data pooled over age, but then conditioned on age in these matrices to form our 
final estimates (with 51, = 51o by assumption). Third. estimates of the quadratic hazard 
function parameters can be obtained using a Newton-Raphson iteration routine with the 
function value, first order partial derivatives, and second order partial derivatives pro- 
grammed as shown in (5.4b), (5.6), and (5.8). Finally, estimation and forecasting of the 
survival function and of the distribution of the risk factors, as described in Section 6, 
require only standard matrix calculations. 
These four steps may be conducted with standard software systems and. except for 
the Newton-Raphson  computations, are extremely inexpensive. Thus, the computations 
presented herein can be practically used for multiple data analyses and for extensive 
simulation studies with a given set of parameter estimates. 
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